Sep 21, 2000
Guidant CEO Ron Dollens Named to the Board of Directors of the Alliance for Aging Research

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that Guidant president and CEO Ron Dollens has been named to the board of directors of the Alliance for Aging Research. Dollens'' nomination to the board was approved at the organization's board meeting Sept. 14 and he will assume his role effective immediately.

"Ron Dollens is a significant leader in the fast-moving world of medical technology," said Daniel Perry, executive director of the Alliance for Aging Research. "He will bring real strength and commitment to the achievable dream of expanding the human experience in healthy and vital aging."

"I am pleased to serve the Alliance and support its pursuit of ground-breaking research and development initiatives," said Dollens. "By advocating the value of innovation and technology, the Alliance has created an environment where citizens, especially seniors, can proactively obtain vital health care information to help them live longer, healthier lives."

In addition to his new role with the Alliance for Aging Research, Dollens is a member of the boards of Advanced Medical Technology Association (AdvaMed, formerly HIMA), Healthcare Leadership Council, Indiana Health Industry Forum, Kennetic Concepts Inc., and Beckman Coulter Corp.

An independent, not-for-profit organization based in Washington, D.C., the Alliance for Aging Research was founded in 1986 and has since become the nation's leading citizen advocacy organization for improving the health and independence of older Americans through scientific and biomedical research. For more information, visit the Alliance website.

A global leader in the medical technology industry, Guidant provides innovative, minimally invasive and cost-effective products and services for the treatment of cardiovascular and vascular disease.